日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisib

使用阿培利西布治疗两名患有PIK3CA相关过度生长谱系疾病的婴儿

Morin, Gabriel; Degrugillier-Chopinet, Caroline; Vincent, Marie; Fraissenon, Antoine; Aubert, Hélène; Chapelle, Célia; Hoguin, Clément; Dubos, François; Catteau, Benoit; Petit, Florence; Mezel, Aurélie; Domanski, Olivia; Herbreteau, Guillaume; Alesandrini, Marie; Boddaert, Nathalie; Boutry, Nathalie; Broissand, Christine; Han, Tianxiang Kevin; Branle, Fabrice; Sarnacki, Sabine; Blanc, Thomas; Guibaud, Laurent; Canaud, Guillaume

Ceritinib Efficacy and Safety in Treatment-Naive Asian Patients With Advanced ALK-Rearranged NSCLC: An ASCEND-4 Subgroup Analysis

塞瑞替尼治疗初治亚洲晚期ALK重排非小细胞肺癌患者的疗效和安全性:ASCEND-4亚组分析

Tan, Daniel S W; Geater, Sarayut; Yu, Chong-Jen; Tsai, Chun-Ming; Hsia, Te-Chun; Chen, Jun; Lin, Meng-Chih; Lu, You; Sriuranpong, Virote; Yang, Cheng-Ta; Sen, Paramita; Branle, Fabrice; Shi, Michael; Wu, Yi-Long

The role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literature

丝裂霉素在非小细胞肺癌治疗中的作用:文献的系统评价和荟萃分析

Sculier, J P; Ghisdal, L; Berghmans, T; Branle, F; Lafitte, J J; Vallot, F; Meert, A P; Lemaitre, F; Steels, E; Burniat, A; Mascaux, C